1 / 7

Fig. 1 Supplement

Fig. 1 Supplement. 70.00. 60.00. 50.00. Fold change. 40.00. mir-10a. mir-130a. 30.00. 20.00. 10.00. 0.00. HELA. MCF7. 293A. JURKAT. NIH/3T3. HL60. COS7. Fig. 2 Supplement. 120. 100. 80. NIH/3T3 HyTK. NIH/3T3 TKpuro. Percentage. 60. NIH/3T3 TKzeo. NIH/3T3 Control. 40.

calida
Download Presentation

Fig. 1 Supplement

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Fig. 1 Supplement

  2. 70.00 60.00 50.00 Fold change 40.00 mir-10a mir-130a 30.00 20.00 10.00 0.00 HELA MCF7 293A JURKAT NIH/3T3 HL60 COS7 Fig. 2 Supplement

  3. 120 100 80 NIH/3T3 HyTK NIH/3T3 TKpuro Percentage 60 NIH/3T3 TKzeo NIH/3T3 Control 40 20 0 0 μM 1 μM 2 μM 3 μM 6 μM 12 μM Concentration GCV Sensitivity Day 10 FIG.3 Supplement

  4. 7 6 5 Fold change 4 3 2 1 0 MCF7+ lib MCF7+ lib + mir-130a Fig. 4 Supplement

  5. Day 1 Day 30 Day 60 Day 70 Fig. 5 Supplement

  6. mir-10a MCF7 MCF7 mir-10a MCF7 mir-130a MCF7 MCF7 mir-10a MCF7 mir-130a Fold change mir-130a MCF7 MCF7 mir-10a MCF7 mir-130a MCF7 MCF7 mir-10a MCF7 mir-130a Transient Stable Fig. 6 Supplement

  7. KIF-AP3 expression 2 NIH/3T3 1.5 2 1 C relative intensity 1 KIFAP3 0.5 0 CYP27A1 cell lysate C 1 2 tubulin CYP71A1 expression 1.4 1.2 1 0.8 0.6 0.4 0.2 0 cell lysate C 1 2 relative intensity Fig. 7 Supplement

More Related